{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:29:24Z","timestamp":1771864164030,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":128,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642307256","type":"print"},{"value":"9783642307263","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-30726-3_11","type":"book-chapter","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T11:24:11Z","timestamp":1349090651000},"page":"211-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Sex and Gender Differences in Cardiovascular Drug Therapy"],"prefix":"10.1007","author":[{"given":"Ute","family":"Seeland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Regitz-Zagrosek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"F934","DOI":"10.1152\/ajprenal.00145.2002","volume":"283","author":"I Armando","year":"2002","unstructured":"Armando I, Jezova M, Juorio AV, Terron JA, Falcon-Neri A, Semino-Mora C, Imboden H, Saavedra JM (2002) Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol 283:F934\u2013F943","journal-title":"Am J Physiol Renal Physiol"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0140-6736(98)09423-9","volume":"353","author":"A Benigni","year":"1999","unstructured":"Benigni A, Remuzzi G (1999) Endothelin antagonists. Lancet 353:133\u2013138","journal-title":"Lancet"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"H2337","DOI":"10.1152\/ajpheart.2001.281.6.H2337","volume":"281","author":"C Berry","year":"2001","unstructured":"Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281:H2337\u2013H2365","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-128-4-199802150-00006","volume":"128","author":"PJ Best","year":"1998","unstructured":"Best PJ, Berger PB, Miller VM, Lerman A (1998) The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128:285\u2013288","journal-title":"Ann Intern Med"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/whe.09.80","volume":"6","author":"P Bhupathy","year":"2010","unstructured":"Bhupathy P, Haines CD, Leinwand LA (2010) Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 6:77\u201395","journal-title":"Womens Health (Lond Engl)"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000074675","volume":"70","author":"A Brandoni","year":"2004","unstructured":"Brandoni A, Villar SR, Torres AM (2004) Gender-related differences in the pharmacodynamics of furosemide in rats. Pharmacology 70:107\u2013112","journal-title":"Pharmacology"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","volume":"434","author":"L Carrel","year":"2005","unstructured":"Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400\u2013404","journal-title":"Nature"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/phrs.2001.0912","volume":"45","author":"JA Cerrutti","year":"2002","unstructured":"Cerrutti JA, Quaglia NB, Brandoni A, Torres AM (2002) Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat. Pharmacol Res 45:107\u2013112","journal-title":"Pharmacol Res"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.V541112","volume":"5","author":"Z Chen","year":"1994","unstructured":"Chen Z, Vaughn DA, Fanestil DD (1994) Influence of gender on renal thiazide diuretic receptor density and response. J Am Soc Nephrol 5:1112\u20131119","journal-title":"J Am Soc Nephrol"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II","year":"1999","unstructured":"CIBIS-II (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"307315","DOI":"10.1155\/2012\/307315","volume":"2012","author":"NE Clarke","year":"2012","unstructured":"Clarke NE, Turner AJ (2012) Angiotensin-converting enzyme 2: the first decade. Int J Hypertens 2012:307315","journal-title":"Int J Hypertens"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1388-9842(02)00040-5","volume":"4","author":"A Coletta","year":"2002","unstructured":"Coletta A, Thackray S, Nikitin N, Cleland JG (2002) Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 4:381\u2013388","journal-title":"Eur J Heart Fail"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1365-2362.2011.02521.x","volume":"41","author":"JM Coulson","year":"2011","unstructured":"Coulson JM, Cockcroft JR (2011) Sex differences in the systemic response to adrenoreceptor antagonists during sympathetic activation. Eur J Clin Invest 41:1129\u20131132","journal-title":"Eur J Clin Invest"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1067\/mcp.2002.128388","volume":"72","author":"CL Cummins","year":"2002","unstructured":"Cummins CL, Wu CY, Benet LZ (2002) Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther 72:474\u2013489","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/bdd.512","volume":"27","author":"S Dadashzadeh","year":"2006","unstructured":"Dadashzadeh S, Javadian B, Sadeghian S (2006) The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Biopharm Drug Dispos 27:329\u2013334","journal-title":"Biopharm Drug Dispos"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1634\/theoncologist.2010-0261","volume":"16","author":"MJ Deenen","year":"2011","unstructured":"Deenen MJ, Cats A, Beijnen JH, Schellens JH (2011) Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects. Oncologist 16:1006\u20131020","journal-title":"Oncologist"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/hy1101.096114","volume":"38","author":"J Deinum","year":"2001","unstructured":"Deinum J, van Gool JM, Kofflard MJ, ten Cate FJ, Danser AH (2001) Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension 38:1278\u20131281","journal-title":"Hypertension"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"DIG","year":"1997","unstructured":"DIG (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336:525\u2013533","journal-title":"N Engl J Med"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-2125.1999.00910.x","volume":"47","author":"K Dilger","year":"1999","unstructured":"Dilger K, Eckhardt K, Hofmann U, Kucher K, Mikus G, Eichelbaum M (1999) Chronopharmacology of intravenous and oral modified release verapamil. Br J Clin Pharmacol 47:413\u2013419","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cardiores.2004.03.027","volume":"63","author":"XJ Du","year":"2004","unstructured":"Du XJ (2004) Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res 63:510\u2013519","journal-title":"Cardiovasc Res"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.physiol.67.040403.120151","volume":"67","author":"DP Edwards","year":"2005","unstructured":"Edwards DP (2005) Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67:335\u2013376","journal-title":"Annu Rev Physiol"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0022-3565(24)37427-0","volume":"285","author":"A Ergul","year":"1998","unstructured":"Ergul A, Shoemaker K, Puett D, Tackett RL (1998) Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exp Ther 285:511\u2013517","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H (2002) Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53:672\u2013677","journal-title":"Cardiovasc Res"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450\u20131456","journal-title":"JAMA"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1172\/JCI8609","volume":"105","author":"CE Gariepy","year":"2000","unstructured":"Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M (2000) Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105:925\u2013933","journal-title":"J Clin Invest"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/01.CIR.0000012546.20194.33","volume":"105","author":"JK Ghali","year":"2002","unstructured":"Ghali JK, Pina IL, Gottlieb SS, Deedwania PC, Wikstrand JC (2002) Metoprolol CR\/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105:1585\u20131591","journal-title":"Circulation"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","volume":"149","author":"GR Gibson","year":"1989","unstructured":"Gibson GR (1989) Enalapril-induced cough. Arch Intern Med 149:2701\u20132703","journal-title":"Arch Intern Med"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/jhh.2010.11","volume":"24","author":"AH Gradman","year":"2010","unstructured":"Gradman AH, Weir MR, Wright M, Bush CA, Keefe DL (2010) Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies. J Hum Hypertens 24:721\u2013729","journal-title":"J Hum Hypertens"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.clpt.2004.07.009","volume":"76","author":"DJ Greenblatt","year":"2004","unstructured":"Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Shader RI (2004) Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin Pharmacol Ther 76:467\u2013479","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1681\/ASN.2007050607","volume":"19","author":"S Guo","year":"2008","unstructured":"Guo S, Kowalewska J, Wietecha TA, Iyoda M, Wang L, Yi K, Spencer M, Banas M, Alexandrescu S, Hudkins KL et al (2008) Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J Am Soc Nephrol 19:1168\u20131176","journal-title":"J Am Soc Nephrol"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2125.1995.tb04554.x","volume":"40","author":"SK Gupta","year":"1995","unstructured":"Gupta SK, Atkinson L, Tu T, Longstreth JA (1995) Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil. Br J Clin Pharmacol 40:325\u2013331","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/clc.4960270510","volume":"27","author":"P Hallberg","year":"2004","unstructured":"Hallberg P, Karlsson J, Lind L, Michaelsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Liljedahl U et al (2004) Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment\u2013results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Clin Cardiol 27:287\u2013290","journal-title":"Clin Cardiol"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0021-9150(95)05710-2","volume":"121","author":"H Hanke","year":"1996","unstructured":"Hanke H, Hanke S, Bruck B, Brehme U, Gugel N, Finking G, Muck AO, Schmahl FW, Hombach V, Haasis R (1996) Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis 121:129\u2013138","journal-title":"Atherosclerosis"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/01.HYP.0000102180.13341.50","volume":"42","author":"LM Harrison-Bernard","year":"2003","unstructured":"Harrison-Bernard LM, Schulman IH, Raij L (2003) Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension 42:1157\u20131163","journal-title":"Hypertension"},{"key":"11_CR35","first-page":"174","volume":"16","author":"BJ Harvey","year":"2001","unstructured":"Harvey BJ, Condliffe S, Doolan CM (2001) Sex and salt hormones: rapid effects in epithelia. News Physiol Sci 16:174\u2013177","journal-title":"News Physiol Sci"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.CIR.92.3.357","volume":"92","author":"WG Haynes","year":"1995","unstructured":"Haynes WG, Strachan FE, Webb DJ (1995) Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92:357\u2013363","journal-title":"Circulation"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/hy0202.103442","volume":"39","author":"M Iglarz","year":"2002","unstructured":"Iglarz M, Benessiano J, Philip I, Vuillaumier-Barrot S, Lasocki S, Hvass U, Durand G, Desmonts JM, Levy BI, Henrion D (2002) Preproendothelin-1 gene polymorphism is related to a change in vascular reactivity in the human mammary artery in vitro. Hypertension 39:209\u2013213","journal-title":"Hypertension"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/CS20100222","volume":"119","author":"M Iglarz","year":"2010","unstructured":"Iglarz M, Clozel M (2010) At the heart of tissue: endothelin system and end-organ damage. Clin Sci (Lond) 119:453\u2013463","journal-title":"Clin Sci (Lond)"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1177\/0091270009359525","volume":"50","author":"V Jarugula","year":"2010","unstructured":"Jarugula V, Yeh CM, Howard D, Bush C, Keefe DL, Dole WP (2010) Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskiren. J Clin Pharmacol 50:1358\u20131366","journal-title":"J Clin Pharmacol"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","volume":"26","author":"N Jochmann","year":"2005","unstructured":"Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V (2005) Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26:1585\u20131595","journal-title":"Eur Heart J"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00508-011-1540-4","volume":"123","author":"CM Kahler","year":"2011","unstructured":"Kahler CM, Graziadei I, Vogelsinger H, Desole S, Cima K, Vogel W (2011) Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan. Wien Klin Wochenschr 123:248\u2013252","journal-title":"Wien Klin Wochenschr"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1752-8062.2009.00094.x","volume":"2","author":"RM Kanashiro-Takeuchi","year":"2009","unstructured":"Kanashiro-Takeuchi RM, Heidecker B, Lamirault G, Dharamsi JW, Hare JM (2009) Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction. Clin Transl Sci 2:134\u2013142","journal-title":"Clin Transl Sci"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clpt.2005.09.007","volume":"79","author":"D Kang","year":"2006","unstructured":"Kang D, Verotta D, Schwartz JB (2006) Population analyses of amlodipine in patients living in the community and patients living in nursing homes. Clin Pharmacol Ther 79:114\u2013124","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2009.10.033","volume":"142","author":"M Kaushik","year":"2010","unstructured":"Kaushik M, Sontineni SP, Hunter C (2010) Cardiovascular disease and androgens: a review. Int J Cardiol 142:8\u201314","journal-title":"Int J Cardiol"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1440-1843.1998.d01-7.x","volume":"3","author":"Y Kawakami","year":"1998","unstructured":"Kawakami Y, Munakata M, Yamaguchi E, Furuya K, Matsuda T (1998) Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough. Respirology 3:45\u201349","journal-title":"Respirology"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1139\/Y10-041","volume":"88","author":"NF Kelland","year":"2010","unstructured":"Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, Gulliver-Sloan FH, Maguire JJ, Davenport AP, Kotelevtsev YV et al (2010) Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88:644\u2013651","journal-title":"Can J Physiol Pharmacol"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1152\/jappl.2001.91.5.2407","volume":"91","author":"DL Kellogg Jr","year":"2001","unstructured":"Kellogg DL Jr, Liu Y, Pergola PE (2001) Selected contribution: gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans. J Appl Physiol 91:2407\u20132411, discussion 2389\u20132490","journal-title":"J Appl Physiol"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2125.1982.tb04948.x","volume":"14","author":"MJ Kendall","year":"1982","unstructured":"Kendall MJ, Quarterman CP, Jack DB, Beeley L (1982) Metoprolol pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol 14:120\u2013122","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000542-199707000-00005","volume":"87","author":"ED Kharasch","year":"1997","unstructured":"Kharasch ED, Russell M, Garton K, Lentz G, Bowdle TA, Cox K (1997) Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe. Anesthesiology 87:26\u201335","journal-title":"Anesthesiology"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0002-9149(97)89205-3","volume":"77","author":"RA Kloner","year":"1996","unstructured":"Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M (1996) Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 77:713\u2013722","journal-title":"Am J Cardiol"},{"key":"11_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1253\/circj.69.138","volume":"69","author":"Y Kokubo","year":"2005","unstructured":"Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H, Naraba H, Tomoike H (2005) Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population\u2013the Suita Study. Circ J 69:138\u2013142","journal-title":"Circ J"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0009-9236(99)70052-4","volume":"66","author":"ME Krecic-Shepard","year":"1999","unstructured":"Krecic-Shepard ME, Barnas CR, Slimko J, Gorski JC, Wainer IW, Schwartz JB (1999) In vivo comparison of putative probes of CYP3A4\/5 activity: erythromycin, dextromethorphan, and verapamil. Clin Pharmacol Ther 66:40\u201350","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/00912700022008883","volume":"40","author":"ME Krecic-Shepard","year":"2000","unstructured":"Krecic-Shepard ME, Barnas CR, Slimko J, Jones MP, Schwartz JB (2000a) Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol 40:219\u2013230","journal-title":"J Clin Pharmacol"},{"key":"11_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1067\/mcp.2000.109356","volume":"68","author":"ME Krecic-Shepard","year":"2000","unstructured":"Krecic-Shepard ME, Barnas CR, Slimko J, Schwartz JB (2000b) Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin Pharmacol Ther 68:286\u2013292","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00008571-200007000-00006","volume":"10","author":"L Labbe","year":"2000","unstructured":"Labbe L, Sirois C, Pilote S, Arseneault M, Robitaille NM, Turgeon J, Hamelin BA (2000) Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates. Pharmacogenetics 10:425\u2013438","journal-title":"Pharmacogenetics"},{"key":"11_CR56","first-page":"H1117","volume":"271","author":"KG Lamping","year":"1996","unstructured":"Lamping KG, Nuno DW (1996) Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. Am J Physiol 271:H1117\u2013H1124","journal-title":"Am J Physiol"},{"key":"11_CR57","first-page":"271","volume":"2","author":"D Lazard","year":"1994","unstructured":"Lazard D, Briend-Sutren MM, Villageois P, Mattei MG, Strosberg AD, Nahmias C (1994) Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues. Receptors Channels 2:271\u2013280","journal-title":"Receptors Channels"},{"key":"11_CR58","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","volume":"98","author":"P Lechat","year":"1998","unstructured":"Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP (1998) Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98:1184\u20131191","journal-title":"Circulation"},{"key":"11_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00204-011-0730-1","volume":"86","author":"SY Lee","year":"2012","unstructured":"Lee SY, Oh SJ, Yun KU, Kim HM, Kim BH, Lee K, Kim SK (2012) Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats. Arch Toxicol 86:75\u201385","journal-title":"Arch Toxicol"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200319429","volume":"112","author":"LA Leinwand","year":"2003","unstructured":"Leinwand LA (2003) Sex is a potent modifier of the cardiovascular system. J Clin Invest 112:302\u2013307","journal-title":"J Clin Invest"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0378-4347(00)84504-1","volume":"342","author":"MS Lennard","year":"1985","unstructured":"Lennard MS (1985) Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatography. J Chromatogr 342:199\u2013205","journal-title":"J Chromatogr"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/clpt.1983.242","volume":"34","author":"MS Lennard","year":"1983","unstructured":"Lennard MS, Tucker GT, Silas JH, Freestone S, Ramsay LE, Woods HF (1983) Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers. Clin Pharmacol Ther 34:732\u2013737","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR63","first-page":"759","volume":"16","author":"M Linnebank","year":"2005","unstructured":"Linnebank M, Fliessbach K, Kolsch H, Rietschel M, Wullner U (2005) The methionine synthase polymorphism c.2756Aright curved arrow G (D919G) is relevant for disease-free longevity. Int J Mol Med 16:759\u2013761","journal-title":"Int J Mol Med"},{"key":"11_CR64","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1172\/JCI119439","volume":"99","author":"KS Lown","year":"1997","unstructured":"Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545\u20132553","journal-title":"J Clin Invest"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1152\/physiolgenomics.00237.2010","volume":"43","author":"ED Luczak","year":"2011","unstructured":"Luczak ED, Barthel KK, Stauffer BL, Konhilas JP, Cheung TH, Leinwand LA (2011) Remodeling the cardiac transcriptional landscape with diet. Physiol Genomics 43:772\u2013780","journal-title":"Physiol Genomics"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/cp.1999.v66.103400001","volume":"66","author":"AB Luzier","year":"1999","unstructured":"Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ (1999) Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther 66:594\u2013601","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-2125.1999.00855.x","volume":"47","author":"FJ Mackay","year":"1999","unstructured":"Mackay FJ, Pearce GL, Mann RD (1999) Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol 47:111\u2013114","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x","volume":"46","author":"RM Martin","year":"1998","unstructured":"Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD (1998) Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 46:505\u2013511","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/FPC.0b013e328348c6db","volume":"21","author":"S Mas","year":"2011","unstructured":"Mas S, Gasso P, Alvarez S, Ortiz J, Sotoca JM, Francino A, Carne X, Lafuente A (2011) Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes. Pharmacogenet Genomics 21:531\u2013538","journal-title":"Pharmacogenet Genomics"},{"key":"11_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/phrs.1997.0202","volume":"36","author":"E Massana","year":"1997","unstructured":"Massana E, Barbanoj MJ, Moros C, Morte A, Gich I, Jane F (1997) No sex-related pharmacokinetic and pharmacodynamic differences of captopril. Pharmacol Res 36:41\u201347","journal-title":"Pharmacol Res"},{"key":"11_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","volume":"41","author":"B Meibohm","year":"2002","unstructured":"Meibohm B, Beierle I, Derendorf H (2002) How important are gender differences in pharmacokinetics? Clin Pharmacokinet 41:329\u2013342","journal-title":"Clin Pharmacokinet"},{"key":"11_CR72","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF","year":"1999","unstructured":"MERIT-HF (1999) Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"11_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.RES.72.3.526","volume":"72","author":"P Molenaar","year":"1993","unstructured":"Molenaar P, O\u2019Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526\u2013538","journal-title":"Circ Res"},{"key":"11_CR74","first-page":"H362","volume":"258","author":"LH Mortensen","year":"1990","unstructured":"Mortensen LH, Fink GD (1990) Hemodynamic effect of human and rat endothelin administration into conscious rats. Am J Physiol 258:H362\u2013H368","journal-title":"Am J Physiol"},{"key":"11_CR75","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","volume":"97","author":"G Nickenig","year":"1998","unstructured":"Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ et al (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97:2197\u20132201","journal-title":"Circulation"},{"key":"11_CR76","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1089\/jwh.2008.0499","volume":"17","author":"EO Ofili","year":"2008","unstructured":"Ofili EO, Cable G, Neutel JM, Saunders E (2008) Efficacy and safety of fixed combinations of irbesartan\/hydrochlorothiazide in hypertensive women: the inclusive trial. J Womens Health (Larchmt) 17:931\u2013938","journal-title":"J Womens Health (Larchmt)"},{"key":"11_CR77","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0140-6736(92)91694-4","volume":"339","author":"I Os","year":"1992","unstructured":"Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S (1992) Female sex as an important determinant of lisinopril-induced cough. Lancet 339:372","journal-title":"Lancet"},{"key":"11_CR78","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"11_CR80","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/cs0900037","volume":"90","author":"C Plumpton","year":"1996","unstructured":"Plumpton C, Ashby MJ, Kuc RE, O\u2019Reilly G, Davenport AP (1996) Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) 90:37\u201346","journal-title":"Clin Sci (Lond)"},{"key":"11_CR82","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","volume":"118","author":"KH Polderman","year":"1993","unstructured":"Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ (1993) Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118:429\u2013432","journal-title":"Ann Intern Med"},{"key":"11_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/HYPERTENSIONAHA.109.139758","volume":"56","author":"DM Pollock","year":"2010","unstructured":"Pollock DM (2010) Dissecting the complex physiology of endothelin: new lessons from genetic models. Hypertension 56:31\u201333","journal-title":"Hypertension"},{"key":"11_CR84","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.289.7.871","volume":"289","author":"SS Rathore","year":"2003","unstructured":"Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289:871\u2013878","journal-title":"JAMA"},{"key":"11_CR85","volume-title":"Sex and gender differences in pharmacology","author":"U Rauch","year":"2012","unstructured":"Rauch U (2012) Gender differences in anticoagulation and antithrombotic therapy. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology. Springer, Heidelberg"},{"key":"11_CR86","volume-title":"Sex and gender differences in pharmacology","author":"L Raz","year":"2012","unstructured":"Raz L, Miller VM (2012) Considerations of sex and gender differences in preclinical and clinical trials. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology. Springer, Heidelberg"},{"key":"11_CR87","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa021266","volume":"347","author":"SS Rathore","year":"2002","unstructured":"Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347:1403\u20131411","journal-title":"N Engl J Med"},{"key":"11_CR88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MNH.0b013e32834f0092","volume":"21","author":"Y Rautureau","year":"2012","unstructured":"Rautureau Y, Schiffrin EL (2012) Endothelin in hypertension: an update. Curr Opin Nephrol Hypertens 21:128\u2013136","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"11_CR89","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrd2032","volume":"5","author":"V Regitz-Zagrosek","year":"2006","unstructured":"Regitz-Zagrosek V (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5:425\u2013438","journal-title":"Nat Rev Drug Discov"},{"key":"11_CR90","first-page":"899","volume":"97","author":"V Regitz-Zagrosek","year":"2004","unstructured":"Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl HB, Hetzer R (2004) Gender aspects in heart failure. Pathophysiology and medical therapy. Arch Mal Coeur Vaiss 97:899\u2013908","journal-title":"Arch Mal Coeur Vaiss"},{"key":"11_CR91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000138825","volume":"43","author":"DW Rosenberg","year":"1991","unstructured":"Rosenberg DW (1991) Dietary modulation of cytochrome P450 in the small intestinal epithelium. Pharmacology 43:36\u201346","journal-title":"Pharmacology"},{"key":"11_CR92","first-page":"533","volume":"18","author":"D Saenz-Campos","year":"1996","unstructured":"Saenz-Campos D, Bayes MC, Masana E, Martin S, Barbanoj M, Jane F (1996) Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril. Methods Find Exp Clin Pharmacol 18:533\u2013538","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"11_CR93","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00005344-199404000-00009","volume":"23","author":"O Saetrum Opgaard","year":"1994","unstructured":"Saetrum Opgaard O, Adner M, Gulbenkian S, Edvinsson L (1994) Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 23:576\u2013583","journal-title":"J Cardiovasc Pharmacol"},{"key":"11_CR94","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/HYPERTENSIONAHA.108.114058","volume":"52","author":"AK Sampson","year":"2008","unstructured":"Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM (2008) Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 52:666\u2013671","journal-title":"Hypertension"},{"key":"11_CR95","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.107.106922","volume":"51","author":"JC Sartori-Valinotti","year":"2008","unstructured":"Sartori-Valinotti JC, Iliescu R, Yanes LL, Dorsett-Martin W, Reckelhoff JF (2008) Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked. Hypertension 51:1170\u20131176","journal-title":"Hypertension"},{"key":"11_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1524-6175.2007.07195.x","volume":"10","author":"E Saunders","year":"2008","unstructured":"Saunders E, Cable G, Neutel J (2008) Predictors of blood pressure response to angiotensin receptor blocker\/diuretic combination therapy: a secondary analysis of the irbesartan\/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study. J Clin Hypertens (Greenwich) 10:27\u201333","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"11_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vph.2005.03.004","volume":"43","author":"EL Schiffrin","year":"2005","unstructured":"Schiffrin EL (2005) Vascular endothelin in hypertension. Vascul Pharmacol 43:19\u201329","journal-title":"Vascul Pharmacol"},{"key":"11_CR98","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/0091270009340417","volume":"50","author":"A Sharma","year":"2010","unstructured":"Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, Belanger PM, Meibohm B, Hamelin BA (2010) Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction. J Clin Pharmacol 50:214\u2013225","journal-title":"J Clin Pharmacol"},{"key":"11_CR99","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/01.CIR.103.3.375","volume":"103","author":"T Simon","year":"2001","unstructured":"Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P (2001) Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 103:375\u2013380","journal-title":"Circulation"},{"key":"11_CR100","volume-title":"Sex and gender differences in pharmacology","author":"I Spoletini","year":"2012","unstructured":"Spoletini I, Vitale C, Malorni W, Rosano GMC (2012) Sex differences in drug effects: interaction with sex hormones in adult life. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology. Springer, Heidelberg"},{"key":"11_CR101","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1152\/ajpregu.00626.2009","volume":"298","author":"BL Stauffer","year":"2010","unstructured":"Stauffer BL, Westby CM, Greiner JJ, Van Guilder GP, Desouza CA (2010) Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol 298:R261\u2013R265","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"11_CR102","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1161\/01.CIR.96.10.3626","volume":"96","author":"K Sudhir","year":"1997","unstructured":"Sudhir K, Ko E, Zellner C, Wong HE, Hutchison SJ, Chou TM, Chatterjee K (1997) Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation 96:3626\u20133632","journal-title":"Circulation"},{"key":"11_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1365-2710.1999.00200.x","volume":"24","author":"E Tanaka","year":"1999","unstructured":"Tanaka E, Hisawa S (1999) Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther 24:7\u201316","journal-title":"J Clin Pharm Ther"},{"key":"11_CR104","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1139\/y05-012","volume":"83","author":"R Tatchum-Talom","year":"2005","unstructured":"Tatchum-Talom R, Eyster KM, Martin DS (2005) Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Can J Physiol Pharmacol 83:413\u2013422","journal-title":"Can J Physiol Pharmacol"},{"key":"11_CR105","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238\u201333243","journal-title":"J Biol Chem"},{"key":"11_CR106","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","volume":"33","author":"L Tiret","year":"1999","unstructured":"Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, Dargie HJ, Arveiler D, Ruidavets JB, Luc G et al (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33:1169\u20131174","journal-title":"Hypertension"},{"key":"11_CR107","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1183\/09031936.93.06040576","volume":"6","author":"A Trifilieff","year":"1993","unstructured":"Trifilieff A, Da Silva A, Gies JP (1993) Kinins and respiratory tract diseases. Eur Respir J 6:576\u2013587","journal-title":"Eur Respir J"},{"key":"11_CR108","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/01.HYP.0000186240.81996.57","volume":"46","author":"ST Turner","year":"2005","unstructured":"Turner ST, Schwartz GL, Chapman AB, Boerwinkle E (2005) WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 46:758\u2013765","journal-title":"Hypertension"},{"key":"11_CR109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/hr.2011.189","volume":"35","author":"K Ueno","year":"2012","unstructured":"Ueno K, Sato H (2012) Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs. Hypertens Res 35:245\u2013250","journal-title":"Hypertens Res"},{"key":"11_CR110","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/0091270007307337","volume":"47","author":"PL van Giersbergen","year":"2007","unstructured":"van Giersbergen PL, Gunawardena KA, Dingemanse J (2007) Influence of ethnic origin and sex on the pharmacokinetics of clazosentan. J Clin Pharmacol 47:1374\u20131380","journal-title":"J Clin Pharmacol"},{"key":"11_CR111","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1164\/ajrccm.159.6.9807060","volume":"159","author":"RJ van Suylen","year":"1999","unstructured":"van Suylen RJ, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Ambergen AW, Vermelis AM, Daemen MJ (1999) The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1791\u20131795","journal-title":"Am J Respir Crit Care Med"},{"key":"11_CR112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ajh.2009.203","volume":"23","author":"M Venegas-Pont","year":"2010","unstructured":"Venegas-Pont M, Sartori-Valinotti JC, Glover PH, Reckelhoff JF, Ryan MJ (2010) Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin-converting enzyme blockade. Am J Hypertens 23:92\u201396","journal-title":"Am J Hypertens"},{"key":"11_CR113","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1100\/tsw.2003.121","volume":"3","author":"TB Vree","year":"2003","unstructured":"Vree TB, Dammers E, Ulc I, Horkovics-Kovats S, Ryska M, Merkx I (2003) Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin. ScientificWorldJournal 3:1332\u20131343","journal-title":"ScientificWorldJournal"},{"key":"11_CR114","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/clpt.1994.115","volume":"56","author":"T Walle","year":"1994","unstructured":"Walle T, Walle K, Mathur RS, Palesch YY, Conradi EC (1994) Propranolol metabolism in normal subjects: association with sex steroid hormones. Clin Pharmacol Ther 56:127\u2013132","journal-title":"Clin Pharmacol Ther"},{"key":"11_CR115","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/mol.109.056705","volume":"76","author":"DJ Waxman","year":"2009","unstructured":"Waxman DJ, Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215\u2013228","journal-title":"Mol Pharmacol"},{"key":"11_CR116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00003088-200847050-00003","volume":"47","author":"D Werner","year":"2008","unstructured":"Werner D, Werner U, Meybaum A, Schmidt B, Umbreen S, Grosch A, Lestin HG, Graf B, Zolk O, Fromm MF (2008) Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers. Clin Pharmacokinet 47:323\u2013332","journal-title":"Clin Pharmacokinet"},{"key":"11_CR117","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0091270009337514","volume":"50","author":"U Werner","year":"2010","unstructured":"Werner U, Werner D, Heinbuchner S, Graf B, Ince H, Kische S, Thurmann P, Konig J, Fromm MF, Zolk O (2010) Gender is an important determinant of the disposition of the loop diuretic torasemide. J Clin Pharmacol 50:160\u2013168","journal-title":"J Clin Pharmacol"},{"key":"11_CR118","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","volume":"348","author":"LM Wing","year":"2003","unstructured":"Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE et al (2003) A comparison of outcomes with angiotensin-converting\u2013enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348:583\u2013592","journal-title":"N Engl J Med"},{"key":"11_CR119","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm1666","volume":"14","author":"A Wirth","year":"2008","unstructured":"Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horvath B, Maser-Gluth C, Greiner E et al (2008) G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 14:64\u201368","journal-title":"Nat Med"},{"key":"11_CR120","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","volume":"38","author":"R Wolbold","year":"2003","unstructured":"Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38:978\u2013988","journal-title":"Hepatology"},{"key":"11_CR121","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/tpj.2009.39","volume":"10","author":"CK Wu","year":"2010","unstructured":"Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT (2010) Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 10:46\u201353","journal-title":"Pharmacogenomics J"},{"key":"11_CR122","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/416334a","volume":"416","author":"HB Xin","year":"2002","unstructured":"Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA et al (2002) Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 416:334\u2013338","journal-title":"Nature"},{"key":"11_CR123","doi-asserted-by":"publisher","first-page":"H2177","DOI":"10.1152\/ajpheart.00969.2004","volume":"288","author":"B Xue","year":"2005","unstructured":"Xue B, Pamidimukkala J, Hay M (2005) Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 288:H2177\u2013H2184","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"11_CR124","doi-asserted-by":"publisher","first-page":"F771","DOI":"10.1152\/ajprenal.90389.2008","volume":"296","author":"LL Yanes","year":"2009","unstructured":"Yanes LL, Sartori-Valinotti JC, Iliescu R, Romero DG, Racusen LC, Zhang H, Reckelhoff JF (2009) Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 296:F771\u2013F779","journal-title":"Am J Physiol Renal Physiol"},{"key":"11_CR125","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/01.CIR.0000156503.62815.48","volume":"111","author":"D You","year":"2005","unstructured":"You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D (2005) High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 111:1006\u20131011","journal-title":"Circulation"},{"key":"11_CR126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/j.1552-4604.1997.tb04766.x","volume":"37","author":"E Yukawa","year":"1997","unstructured":"Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T (1997) Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. J Clin Pharmacol 37:92\u2013100","journal-title":"J Clin Pharmacol"},{"key":"11_CR127","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00005344-200405000-00018","volume":"43","author":"P Zapater","year":"2004","unstructured":"Zapater P, Novalbos J, Gallego-Sandin S, Hernandez FT, Abad-Santos F (2004) Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol 43:737\u2013744","journal-title":"J Cardiovasc Pharmacol"},{"key":"11_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1550-8579(06)80193-2","volume":"3","author":"W Zheng","year":"2006","unstructured":"Zheng W, Shi M, You SE, Ji H, Roesch DM (2006) Estrogens contribute to a sex difference in plasma potassium concentration: a mechanism for regulation of adrenal angiotensin receptors. Gend Med 3:43\u201353","journal-title":"Gend Med"}],"container-title":["Handbook of Experimental Pharmacology","Sex and Gender Differences in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-30726-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:02:32Z","timestamp":1744232552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-30726-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"ISBN":["9783642307256","9783642307263"],"references-count":128,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-30726-3_11","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,5]]},"assertion":[{"value":"5 September 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}